Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.
Baugh R. et al, (2024), J Immunother Cancer, 12
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?
Wan PK-T. et al, (2023), J Immunother Cancer, 11
Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.
Wan PK-T. et al, (2021), Mol Ther, 29, 1668 - 1682
HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.
Wan PK-T. et al, (2021), Cancer Lett, 497, 14 - 27
Role of Nurr1 in Carcinogenesis and Tumor Immunology: A State of the Art Review.
Wan PK-T. et al, (2020), Cancers (Basel), 12
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo X-T. et al, (2020), Br J Cancer, 123, 833 - 843